Literature DB >> 2876554

The effects of diuretics and adrenergic-blocking agents on plasma lipids.

J J Rohlfing, J D Brunzell.   

Abstract

ANTIHYPERTENSIVE MEDICATIONS CAUSE THE FOLLOWING CHANGES IN PLASMA LIPIDS AND LIPOPROTEINS: Thiazide and loop diuretics increase triglyceride, total cholesterol and low-density-lipoprotein (LDL) cholesterol levels with no change in high-density-lipoprotein (HDL) cholesterol. beta-Adrenergic antagonists increase triglyceride and decrease HDL cholesterol levels. A rise in very-low-density-lipoprotein (VLDL) cholesterol balances the decrease in HDL cholesterol, so that there is no significant change in total cholesterol. alpha-Adrenergic antagonists decrease triglyceride, increase HDL cholesterol and may decrease VLDL and LDL cholesterol. Labetalol, with both alpha- and beta-adrenergic antagonistic activity, does not affect plasma lipids in a small number of studies. The calcium channel blockers nifedipine and verapamil also have no consistent effect on lipoprotein levels in a small number of studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876554      PMCID: PMC1306877     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  70 in total

1.  Comparison of in vitro and in vivo effects of prazosin on lipid metabolism.

Authors:  H Kather; P Säuberlich
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

2.  Serum lipoproteins after treatment with verapamil for 6 months.

Authors:  O Faergeman; H Meinertz; J F Hansen
Journal:  Acta Med Scand Suppl       Date:  1984

3.  Effect of atenolol on plasma HDL cholesterol subfractions.

Authors:  A Lehtonen; J Marniemi
Journal:  Atherosclerosis       Date:  1984 May-Jun       Impact factor: 5.162

4.  Effect of verapamil on serum lipoproteins in patients with angina pectoris.

Authors:  G Walldius
Journal:  Acta Med Scand Suppl       Date:  1984

5.  Effects of prazosin and propranolol on serum lipids in patients with essential hypertension.

Authors:  J Lowenstein; A J Neusy
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

6.  Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.

Authors:  Y Goto
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

7.  Effects of long-term prazosin therapy on lipoprotein metabolism in hypertensive patients.

Authors:  T Takabatake; H Ohta; M Maekawa; Y Yamamoto; Y Ishida; H Hara; N Hattori
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

8.  Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial.

Authors:  N L Lasser; G Grandits; A W Caggiula; J A Cutler; R H Grimm; L H Kuller; R W Sherwin; J Stamler
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

9.  Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.

Authors:  M B Murphy; D Sugrue; I Trayner; S Kaufman; H Yasuhara; C T Dollery; G R Thompson
Journal:  Br Heart J       Date:  1984-06

10.  Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol.

Authors:  C A Dujovne; S DeCoursey; P Krehbiel; B Jackson; S Chernoff
Journal:  Clin Pharmacol Ther       Date:  1984-08       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.